Business

Directors' / PDMRs' Interests in Shares

Directors' / PDMRs' Interests in Shares.

articleSynectics PlcAugust 10, 20204/company/synectics-plc/news/directors-pdmrs-interests-in-shares-1
Directors' / PDMRs' Interests in Shares

About this update from Synectics Plc

[{"type":"text","content":"\n \n \n RNS Number : 5557V\n Synectics PLC\n 10 August 2020\n  \n \n \n \n  \n \n \n  \n \n \n  \n \n \n Synectics plc\n \n \n (the \"Company\")\n \n \n  \n \n \n Directors' / PDMRs' Interests in Shares\n \n \n  \n \n \n Synectics plc (AIM: SNX), a leader in the design, integration and support of advanced security and surveillance systems,\n announces that on 7 August 2020 it made an award of options (\"Options\"), in aggregate, over 546,000 ordinary shares of 20p each in the Company (\"Ordinary Shares\") to certain Directors and Persons Discharging Managerial Responsibility (\"PDMRs\"), under its existing Performance Share Plan (\"PSP\"), as detailed below:\n \n \n  \n \n \n Director Options\n \n \n  \n \n \n \n \n \n \n Name\n \n \n \n \n Position\n \n \n \n \n Number of Options\n \n \n \n \n \n \n Paul Webb\n \n \n \n \n Chief Executive Officer\n \n \n \n \n 300,000\n \n \n \n \n \n \n David Bedford\n \n \n \n \n Group Finance Director\n \n \n \n \n 186,000\n \n \n \n \n \n \n  \n \n \n Following these awards, their total interests in Ordinary Shares comprise:\n \n \n  \n \n \n \n \n \n \n  \n \n \n  \n \n \n  \n \n \n Name\n \n \n \n \n  \n \n \n Number of\n \n \n Ordinary Shares held\n \n \n \n \n Interest in Ordinary Shares in Synectics plc share schemes\n \n \n \n \n  \n \n \n Resultant total interest in Ordinary Shares\n \n \n \n \n  \n \n \n % of issued share capital\n \n \n \n \n \n \n Paul Webb\n \n \n \n \n 57,115\n \n \n \n \n 533,909\n \n \n \n \n 591,024\n \n \n \n \n 3.32%\n \n \n \n \n \n \n David Bedford\n \n \n \n \n 5,000\n \n \n \n \n 186,000\n \n \n \n \n 191,000\n \n \n \n \n 1.07%\n \n \n \n \n \n \n  \n \n \n The above one-off awards vest over a five-year period up to the end of the Company's financial year ending 30 November 2025. The Options are divided into three equal tranches, vesting after the next three, four and five full financial years respectively, depending on the achievement of the performance criteria at each measurement date and are exercisable at nil cost.  All Options must be exercised within ten years of the date of award. \n \n \n  \n \n \n The performance criteria will be measured according to the average of the Compound Annual Growth Rate (\"CAGR\") of the Total Shareholder Retur...

More updates from Synectics Plc